Dynamic Contrast-Enhanced MRI in Patients with Brain Metastases Undergoing Laser Interstitial Thermal Therapy: A Pilot Study

REFERENCES

1. 1.↵
   2. Schouten LJ,
   3. Rutten J,
   4. Huveneers HA, et al

   . Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002;94:2698–705 doi:10.1002/cncr.10541 pmid:12173339

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Lin X,
   3. DeAngelis LM

   . Treatment of brain metastases. J Clin Oncol 2015;33:3475–84 doi:10.1200/JCO.2015.60.9503 pmid:26282648

   Abstract/FREE Full Text
3. 3.↵
   2. De Poorter J

   . Noninvasive MRI thermometry with the proton resonance frequency method: study of susceptibility effects. Magn Reson Med 1995;34:359–67 doi:10.1002/mrm.1910340313 pmid:7500875

   CrossRefPubMed
4. 4.↵
   2. Carpentier A,
   3. McNichols RJ,
   4. Stafford RJ, et al

   . Laser thermal therapy: real-time MRI-guided and computer-controlled procedures for metastatic brain tumors. Lasers Surg Med 2011;43:943–50 doi:10.1002/lsm.21138 pmid:22109661

   CrossRefPubMed
5. 5.↵
   2. Patel TR,
   3. McHugh BJ,
   4. Bi WL, et al

   . A comprehensive review of MR imaging changes following radiosurgery to 500 brain metastases. AJNR Am J Neuroradiol 2011;32:1885–92 doi:10.3174/ajnr.A2668 pmid:21920854

   Abstract/FREE Full Text
6. 6.↵
   2. Yankeelov TE,
   3. Gore JC

   . Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples. Curr Med Imaging Rev 2009;3:91–107 doi:10.2174/157340507780619179 pmid:19829742

   CrossRefPubMed
7. 7.↵
   2. Walker AJ,
   3. Ruzevick J,
   4. Malayeri AA, et al

   . Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression? Future Oncol 2014;10:1277–97 doi:10.2217/fon.13.271 pmid:24947265

   CrossRefPubMed
8. 8.↵
   2. Rieber A,
   3. Brambs HJ,
   4. Gabelmann A, et al

   . Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 2002;12:1711–19 doi:10.1007/s00330-001-1233-x pmid:12111062

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Choi YJ,
   3. Lee JH,
   4. Sung YS, et al

   . Value of dynamic contrast-enhanced MRI to detect local tumor recurrence in primary head and neck cancer patients. Medicine 2016;95:e3698 doi:10.1097/MD.0000000000003698 pmid:27175712

   CrossRefPubMed
10. 10.↵
    2. Narang J,
    3. Jain R,
    4. Arbab AS, et al

    . Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion. Neuro Oncol 2011;13:1037–46 doi:10.1093/neuonc/nor075 pmid:21803763

    CrossRefPubMed
11. 11.↵
    2. Chung WJ,
    3. Kim HS,
    4. Kim N, et al

    . Recurrent glioblastoma: optimum area under the curve method derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging. Radiology 2013;269:561–68 doi:10.1148/radiol.13130016 pmid:23878286

    CrossRefPubMed
12. 12.↵
    2. Hatzoglou V,
    3. Yang TJ,
    4. Omuro A, et al

    . A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation. Neuro Oncol 2016;18:873–80 doi:10.1093/neuonc/nov301 pmid:26688076

    CrossRefPubMed
13. 13.↵
    2. Lin NU,
    3. Lee EQ,
    4. Aoyama H, et al

    ; Response Assessment in Neuro-Oncology (RANO) group. Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 2015;16:e270–78 doi:10.1016/S1470-2045(15)70057-4 pmid:26065612

    CrossRefPubMed
14. 14.↵
    2. Thomas JG,
    3. Rao G,
    4. Kew Y, et al

    . Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma. Neurosurg Focus 2016;41:E12 doi:10.3171/2016.7.FOCUS16234 pmid:27690657

    CrossRefPubMed
15. 15.↵
    2. Fedorov A,
    3. Beichel R,
    4. Kalpathy-Cramer J, et al

    . 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 2012;30:1323–41 doi:10.1016/j.mri.2012.05.001 pmid:22770690

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Missios S,
    3. Bekelis K,
    4. Barnett GH

    . Renaissance of laser interstitial thermal ablation. Neurosurg Focus 2015;38:E13 doi:10.3171/2014.12.FOCUS14762 pmid:25727222

    CrossRefPubMed
17. 17.↵
    2. Choi YS,
    3. Lee HJ,
    4. Ahn SS, et al

    . Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient. Eur Radiol 2017;27:1344–51 doi:10.1007/s00330-016-4484-2 pmid:27436023

    CrossRefPubMed
18. 18.↵
    2. Therneau TM,
    3. Grambsch PM

    . Modeling Survival Data: Extending the Cox Model. Springer, New York; 2000
19. 19.↵
    2. Kuhn M

    . Caret: classification and regression training. Astrophysics Source Code Library 2015. https://CRAN.R-project.org/package=caret. Accessed April 21, 2019.
20. 20.↵
    2. Robin X,
    3. Turck N,
    4. Hainard A, et al

    . pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011. https://CRAN.R-project.org/package=pROC;12:77. Accessed April 21, 2019.
21. 21.↵
    2. Wickham H

    . ggplot2: Create Elegant Data Visualisations Using the Grammar of Graphics. Springer-Verlag; 2016. https://CRAN.R-project.org/package=ggplot2. Accessed April 21, 2019.
22. 22.↵
    2. Kassambara A,
    3. Kosinski A,
    4. Biecek P, et al

    . Survminer: drawing survival curves using 'ggplot2′. 2019. https://CRAN.R-project.org/package=survminer. Accessed April 21, 2019.
23. 23.↵
    2. Youden WJ

    . Index for rating diagnostic tests. Cancer 1950;3:32–35 pmid:15405679

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Hygino da Cruz LC Jr.,
    3. Rodriguez I,
    4. Domingues RC, et al

    . Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. AJNR Am J Neuroradiol 2011;32:1978–85 doi:10.3174/ajnr.A2397 pmid:21393407

    Abstract/FREE Full Text
25. 25.↵
    2. Elster AD,
    3. DiPersio DA

    . Cranial postoperative site: assessment with contrast-enhanced MR imaging. Radiology 1990;174:93–98 doi:10.1148/radiology.174.1.2294578 pmid:2294578

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Salehi A,
    3. Kamath AA,
    4. Leuthardt EC, et al

    . Management of intracranial metastatic disease with laser interstitial thermal therapy. Front Oncol 2018;8:499 doi:10.3389/fonc.2018.00499 pmid:30430083

    CrossRefPubMed
27. 27.↵
    2. Larsen VA,
    3. Simonsen HJ,
    4. Law I, et al

    . Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis. Neuroradiology 2013;55:361–69 doi:10.1007/s00234-012-1127-4 pmid:23262559

    CrossRefPubMed
28. 28.↵
    2. Hatzoglou V,
    3. Tisnado J,
    4. Mehta A, et al

    . Dynamic contrast-enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases. Cancer Med 2017;6:761–67 doi:10.1002/cam4.1046 pmid:28303695

    CrossRefPubMed
29. 29.↵
    2. Choi YS,
    3. Ahn SS,
    4. Lee HJ, et al

    . The initial area under the curve derived from dynamic contrast-enhanced MRI improves prognosis prediction in glioblastoma with unmethylated MGMT promoter. AJNR Am J Neuroradiol 2017;38:1528–35 doi:10.3174/ajnr.A5265 pmid:28642265

    Abstract/FREE Full Text
30. 30.↵
    2. Giglio P,
    3. Gilbert MR

    . Cerebral radiation necrosis. Neurologist 2003;9:180–88 doi:10.1097/01.nrl.0000080951.78533.c4 pmid:12864928

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Gasparetto EL,
    3. Pawlak MA,
    4. Patel SH, et al

    . Posttreatment recurrence of malignant brain neoplasm: accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction. Radiology 2009;250:887–96 doi:10.1148/radiol.2502071444 pmid:19244052

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Artzi M,
    3. Liberman G,
    4. Nadav G, et al

    . Differentiation between treatment-related changes and progressive disease in patients with high grade brain tumors using support vector machine classification based on DCE MRI. J Neurooncol 2016;127:515–24 doi:10.1007/s11060-016-2055-7 pmid:26754857

    CrossRefPubMed
33. 33.↵
    2. Bolcaen J,
    3. Descamps B,
    4. Acou M, et al

    . In vivo DCE-MRI for the discrimination between glioblastoma and radiation necrosis in rats. Mol Imaging Biol 2017;19:857–66 doi:10.1007/s11307-017-1071-0 pmid:28303489

    CrossRefPubMed
34. 34.↵
    2. Mitsuya K,
    3. Nakasu Y,
    4. Horiguchi S, et al

    . Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J Neurooncol 2010;99:81–88 doi:10.1007/s11060-009-0106-z pmid:20058049

    CrossRefPubMed
35. 35.↵
    2. Jesberger JA,
    3. Rafie N,
    4. Duerk JL, et al

    . Model-free parameters from dynamic contrast-enhanced-MRI: sensitivity to EES volume fraction and bolus timing. J Magn Reson Imaging 2006;24:586–94 doi:10.1002/jmri.20670 pmid:16892197

    CrossRefPubMed
36. 36.↵
    2. Sharma M,
    3. Balasubramanian S,
    4. Silva D, et al

    . Laser interstitial thermal therapy in the management of brain metastasis and radiation necrosis after radiosurgery: an overview. Expert Rev Neurother 2016;16:223–32 doi:10.1586/14737175.2016.1135736 pmid:26731270

    CrossRefPubMed
37. 37.↵
    2. Schulze PC,
    3. Vitzthum HE,
    4. Goldammer A, et al

    . Laser-induced thermotherapy of neoplastic lesions in the brain–underlying tissue alterations, MRI-monitoring and clinical applicability. Acta Neurochir (Wien) 2004;146:803–12 pmid:15254802

    PubMed
38. 38.↵
    2. Fidler IJ,
    3. Yano S,
    4. Zhang RD, et al

    . The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol 2002;3:53–57 doi:10.1016/S1470-2045(01)00622-2 pmid:11905606

    CrossRefPubMedWeb of Science
39. 39.↵
    2. Medvid R,
    3. Ruiz A,
    4. Komotar RJ, et al

    . Current applications of MRI-guided laser interstitial thermal therapy in the treatment of brain neoplasms and epilepsy: a radiologic and neurosurgical overview. AJNR Am J Neuroradiol 2015;36:1998–2006 doi:10.3174/ajnr.A4362 pmid:26113069

    Abstract/FREE Full Text